Argon Medical Devices have helped set the standard for Pulmonary Embolism (PE) removal and Vena Cava Filters with their Option system. The company, based out of Plano, Texas, has now announced the release of an improved system called the OptionELITE.
The aim of the ELITE was to continue to fix the flaws that were inherent in the original Option, namely safety and retrievability. Where the Option was good, Argon was trying for something great that would reduce the number of deaths from PE.
Pulmonary Embolisms are one of the leading causes of in-hospital death in the nation, in large part because the equipment is not available that allows medical personnel to capture, access, and remove the blood clot safely.
The issue is often one of force and penetration. In attempting to create a framework for capturing the blood clot (embolism) from the blood vessels around the lungs (pulmonary artery), more finesse is required than anywhere else in the body, due to the proximity to the airways. A mechanism that requires too much force to be put in place can easily perforate the lung sacs or will force the clot to migrate deeper. With Vena Cava filters, the retrieval of the filtration system itself can be deadly.
“I have used OptionTM for many years. At Weill Cornell, we had the opportunity to participate in the OptionELITE evaluation and found the device to be just as safe and stable as the Option, with no migrations and significantly easier to retrieve,” said Dr. David W. Trost, Associate Professor of Clinical Radiology with the Weill Medical College of Cornell University in New York.
The current mortality rate of PE is between 600,000 and 1,000,000 people and climbing each year, and a serviceable filtration method was needed that would allow fast access without the fumbling that came as part and parcel with certain machines.
Hopefully Argon’s OptionELITE will be able to somewhat arrest the rising issue of arterial blockages and make hospitals safer for patients.